New drugs 04, part 1

Nursing. 2004 Feb;34(2):56-62; quiz 63-4. doi: 10.1097/00152193-200402000-00050.
No abstract available

MeSH terms

  • Adalimumab
  • Alefacept
  • Anisoles / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Antioxidants / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Atomoxetine Hydrochloride
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Drug Approval*
  • Drug Therapy / nursing
  • Drug Therapy / standards
  • Drug Therapy / trends*
  • Fabry Disease / drug therapy
  • Gefitinib
  • Humans
  • Iduronidase / therapeutic use
  • Indoles / therapeutic use
  • Isoenzymes / therapeutic use
  • Lentigo / drug therapy
  • Lung Neoplasms / drug therapy
  • Migraine Disorders / drug therapy
  • Mucopolysaccharidosis I / drug therapy
  • Nitro Compounds
  • Patient Education as Topic
  • Propylamines / therapeutic use
  • Psoriasis / drug therapy
  • Pyrrolidines / therapeutic use
  • Quinazolines / therapeutic use
  • Recombinant Fusion Proteins / therapeutic use
  • Serotonin Receptor Agonists / therapeutic use
  • Thiazoles / therapeutic use
  • Tryptamines
  • alpha-Galactosidase / therapeutic use

Substances

  • Anisoles
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Antioxidants
  • Antiprotozoal Agents
  • Antirheumatic Agents
  • Indoles
  • Isoenzymes
  • Nitro Compounds
  • Propylamines
  • Pyrrolidines
  • Quinazolines
  • Recombinant Fusion Proteins
  • Serotonin Receptor Agonists
  • Thiazoles
  • Tryptamines
  • eletriptan
  • Atomoxetine Hydrochloride
  • mequinol
  • alpha-Galactosidase
  • Iduronidase
  • Alefacept
  • Adalimumab
  • agalsidase beta
  • Gefitinib
  • nitazoxanide